137 related articles for article (PubMed ID: 23422504)
1. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies.
Lee JY; Myung SK; Song YS
Gynecol Oncol; 2013 Jun; 129(3):613-9. PubMed ID: 23422504
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis.
Huang M; Chen Q; Xiao J; Liu C; Zhao X
Int J Cancer; 2013 Jan; 132(2):363-73. PubMed ID: 22729746
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis.
Sun S; Cai J; Yang Q; Zhu Y; Zhao S; Wang Z
PLoS One; 2016; 11(11):e0166058. PubMed ID: 27812204
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
5. COX-2 expression in ovarian cancer: an updated meta-analysis.
Sun H; Zhang X; Sun D; Jia X; Xu L; Qiao Y; Jin Y
Oncotarget; 2017 Oct; 8(50):88152-88162. PubMed ID: 29152148
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang Z; Gu JH; Guo CS; Li XH; Yang WC
Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
[TBL] [Abstract][Full Text] [Related]
7. Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.
Beeghly-Fadiel A; Wilson AJ; Keene S; El Ramahi M; Xu S; Marnett LJ; Fadare O; Crispens MA; Khabele D
J Ovarian Res; 2018 Feb; 11(1):17. PubMed ID: 29482584
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
Jia H; Zhang Q; Liu F; Zhou D
Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
Li LN; Zhou X; Gu Y; Yan J
Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
[TBL] [Abstract][Full Text] [Related]
10. Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang HS; Yoon C; Myung SK; Park SM
Int J Gynecol Cancer; 2011 Dec; 21(9):1525-32. PubMed ID: 22080892
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.
Klar M; Hasenburg A; Hasanov M; Hilpert F; Meier W; Pfisterer J; Pujade-Lauraine E; Herrstedt J; Reuss A; du Bois A
Eur J Cancer; 2016 Oct; 66():114-24. PubMed ID: 27561452
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
Skírnisdóttir I; Seidal T
Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
[TBL] [Abstract][Full Text] [Related]
13. Correlation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis.
Fang J; Guo X; Zheng B; Han W; Chen X; Zhu J; Xie B; Liu J; Luan X; Yan Y; He Z; Li H; Qiao C; Yu J
Arch Gynecol Obstet; 2018 Feb; 297(2):449-458. PubMed ID: 29274004
[TBL] [Abstract][Full Text] [Related]
14. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: A meta-analysis.
Yang B; Jia L; Guo Q; Ren H; Hu Y; Xie T
Oncotarget; 2016 Jul; 7(30):47265-47277. PubMed ID: 27323811
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of systematic retroperitoneal lymphadenectomy in patients with epithelial ovarian cancer: a Meta-analysis].
Gu HF; Zhou Y; Li YX; Ou YL; Liu JH
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):3020-3025. PubMed ID: 27760666
[No Abstract] [Full Text] [Related]
17. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
[TBL] [Abstract][Full Text] [Related]
20. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.
Liu P; Wang Y; Tong L; Xu Y; Zhang W; Guo Z; Ni H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1163-71. PubMed ID: 26542279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
